Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Camostat Mesylate in COVID-19 Associated Coagulopathy
NCT04435015Phase 2Withdrawn
- Sponsor
- Yale University
- Start
- Nov 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of camostat mesilate in COVID-19 associated coagulopathy (CAC), sponsored by Yale University. Planned start Nov 2021; status: withdrawn.
02
Drugs
camostat mesilate
03
Conditions
COVID-19 associated coagulopathy (CAC)
Beyond the preview
Go deeper on NCT04435015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04435015.